Quantitative analysis for 4D Molecular Therapeutics Inc. Common Stock (FDMT) — Health Care: AI-powered alpha score, Benjamin Graham intrinsic value, ML-based forecast, technical and fundamental signals, and insider activity.
Current Q-Score verdict: Buy (66.0) (grade B). 24 signals analyzed (19 differentiated alt-data).
FDMT stock price is tracked daily for technical and fundamental analysis. The data below shows recent trading activity used in trend analysis, momentum calculation, and entry/exit signals.
| Date | High | Low | Close |
|---|---|---|---|
| 2026-04-08 | $10.88 | $9.95 | $10.10 |
| 2026-04-20 | $10.59 | $10.01 | $10.07 |
| 2026-04-30 | $9.07 | $8.64 | $8.87 |
| 2026-05-12 | $10.86 | $10.24 | $10.34 |
| 2026-05-22 | $8.90 | $8.55 | $8.60 |
| 2026-06-04 | $10.45 | $9.54 | $10.01 |
| 2026-06-16 | $9.23 | $8.55 | $8.67 |
| 2026-06-29 | $13.33 | $11.68 | $12.88 |
| 2026-07-10 | $13.01 | $11.57 | $12.31 |
| 2026-07-22 | $11.43 | $10.91 | $10.96 |
| 2026-08-03 | $10.33 | $9.66 | $10.09 |
| 2026-08-14 | $12.35 | $11.26 | $12.19 |
How 4D Molecular Therapeutics Inc. Common Stock stacks up against same-sector peers on market capitalization and alpha scores:
| Ticker | Company | Market Cap | Alpha Score |
|---|---|---|---|
| AZN | AstraZeneca PLC | $290.7B | — |
| NVS | Novartis AG | $287.1B | — |
| NVO | Novo Nordisk A/S | $200.3B | — |
| SNY | Sanofi | $107.6B | — |
View all Health Care stocks by valuation and signals →
4D Molecular Therapeutics Inc. Common Stock (FDMT) scores Buy (66.0), with no measured dimension below 51. Its highest are technicals at 97, analyst consensus at 89, competitive moat at 77, across 5 measured dimensions. See Q-Score methodology for how these dimensions are weighted and combined.
| Dimension | Score |
|---|---|
| technicals | 97 |
| analyst consensus | 89 |
| competitive moat | 77 |
| valuation | 73 |
| earnings quality | 51 |
StoQuant analyzes 24 signals (19 alt-data). Alternative data sources (FDA approvals, GitHub activity, SEC filings, App Store ratings) complement traditional financial metrics.
All StoQuant signals are explained in our knowledge base:
Health Care Hub — Top performers and valuation outliers in Health Care
Get daily updates on 4D Molecular Therapeutics Inc. Common Stock (FDMT): Q-Score changes, insider transactions, forecast shifts, sector rotation, and macroeconomic context. The StoQuant digest curates the most material signals for your watchlist — free, no account required.
See a sample digest • Unsubscribe anytime • Privacy policy
StoQuant is a quantitative stock research platform powered by AI scoring, fundamental analysis, and institutional-grade signals. We cover 3,600+ US-listed equities with daily updates on valuations, earnings quality, insider flow, and ML-based return forecasts. Learn more about us.
Share this stock's latest Q-Score and alpha score on your website, GitHub README, or blog. The SVG badge auto-updates daily:
<a href="https://stoquant.com/research/FDMT"><img src="https://stoquant.com/badge/FDMT.svg" alt="4D Molecular Therapeutics Inc. Common Stock (FDMT) Q-Score and Alpha on StoQuant" width="240" height="64" /></a>
StoQuant research is generated algorithmically using public market data, SEC filings, news feeds, and proprietary ML models. Not investment advice. Past performance does not guarantee future results.
Daily Q-Score changes, insider buy clusters, and ML forecast updates for the tickers you follow. Email only, no account needed. See a sample digest.